References
- Unfer V, Orrù B, Monastra G. Inositols: from physiology to rational therapy in gynecological clinical practice. Expert Opin Drug Metab Toxicol. 2016;12(10):1129–1131.
- Laganà AS, Rossetti P, Buscema M, et al. Metabolism and ovarian function in pcos women: a therapeutic approach with inositols. Int J Endocrinol. 2016;2016:1–9.
- Paul C, Laganà AS, Maniglio P, et al. Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecol Endocrinol. 2016;32(6):431–438.
- Gulino FA, Leonardi E, Marilli I, et al. Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: in vivo study. Gynecol Endocrinol. 2016;32(1):65–68.
- Vitale SG, Rossetti P, Corrado F, et al. How to achieve high-quality oocytes? the key role of myo-inositol and melatonin. Int J Endocrinol. 2016;2016:1–9.